论文部分内容阅读
目的:观察注射用葛根素辅助脑蛋白水解物治疗缺血性脑血管疾病的疗效。方法:治疗组56例,用20 mL脑蛋白水解物加入0.9%氯化钠注射液250 mL,静脉滴注,qd,再用400 mg葛根素加入10%葡萄糖注射液500 mL,静脉滴注,qd。对照组56例,用20 mL脑蛋白水解物加入0.9%氯化钠注射液250 mL,静脉滴注。2组均15 d为一个疗程。同时对血液流变学指标进行观察。结果:治疗组有效率为92.86%,对照组有效率为82.14%,2组比较差异显著(P<0.05)治疗组血液流变学指标较对照组均有不同程度的下降,差异显著(P<0.05)。结论:葛根素与脑蛋白水解物联用治疗缺血性脑血管疾病效果优于单用脑蛋白水解物。
Objective: To observe the efficacy of puerarin-assisted brain protein hydrolyzate for the treatment of ischemic cerebrovascular diseases. Methods: The treatment group of 56 cases, with 20 mL of brain hydrolyzate added 0.9% sodium chloride injection 250 mL, intravenous infusion, qd, 400 mg of puerarin and then added 10% glucose injection 500 mL, intravenous infusion, qd. Control group, 56 cases, with 20 mL of brain protein hydrolyzate added 0.9% sodium chloride injection 250 mL, intravenous infusion. Both groups were 15 days for a course of treatment. At the same time hemorheology indicators were observed. Results: The effective rate was 92.86% in the treatment group and 82.14% in the control group, with significant difference between the two groups (P <0.05). The hemorrheological indexes in the treatment group decreased to some extent compared with the control group (P < 0.05). Conclusion: The combination of puerarin and brain protein hydrolyzate is better than single brain protein hydrolyzate in the treatment of ischemic cerebrovascular diseases.